Inflammation Drives Coagulopathies in Sars-Cov-2 Patients

Background:A hypercoagulable state has been consistently reported in patients with severe Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), characterized by elevated D-dimer, prolonged PT, and mild thrombocytopenia, though the mechanism is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Martha MS, Banerjee, Meenakshi, Hollifield, Melissa, Alfar, Hammodah, Li, Xian, Thornton, Alice, Porterfield, James Z, Sturgill, Jamie, Sievert, Gail A, Barton-Baxter, Marietta, Campbell, Kenneth S, Woodward, Jerold G, Whiteheart, Sidney W, Garvy, Beth A, Wood, Jeremy P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
331.Pathophysiology of Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330215/
http://dx.doi.org/10.1182/blood-2020-142848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330215/
http://dx.doi.org/10.1182/blood-2020-142848

Ejemplares similares